BMC Infectious Diseases

Table 2 Summaries of prevalence survey results and drug resistance survey data for Philippines and Viet Nam

From: Estimating tuberculosis drug resistance amplification rates in high-burden settings

A) TB prevalence data
Country	Year	TB prevalence (per 100, 000)	95% CI	Sources
Viet Nam	2006–2007	307.2	248.8–365.6	[24]
Viet Nam	2017–2018	322	260–399	[25]
The Philippines	2007	660	510–810	[26]
The Philippines	2016	1159	1016–1301	[27]

B) Drug resistance data
Country	Drug resistance	Year	Drug resistance (%)	95% CI	Sources
Viet Nam	Isoniazid mono resistance	2011	14.86	12.15–17.56	[28]
	Rifampicin mono resistance	2011	0.23	0.1–0.35	[28]
	MDR-TB	2011	6.93	4.22–9.63	[28]
The Philippines	Isoniazid mono resistance	2009	9.44	7.95–10.92	[29]
	Rifampicin mono resistance	2009	1.008	0.71–1.304	[29]
	MDR-TB	2009	5.8	4.3–7.5	[29]
The Philippines	Isoniazid mono resistance	2016	12.43	11.1–13.75	[27]
	Rifampicin mono resistance	2016	0.82	0.44–1.19	[27]
	MDR-TB	2016	3.35	2.53–4.41	[27]

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com